Studies related to Fecal Weight and Colostrum

Treatment Of Severe Diarrhea Caused By Cryptosporidium Parvum With Oral Bovine Immunoglobulin Concentrate In Patients With AIDS

Effect Decrease
Trial Design Cohort
Trial Length 2-4 Weeks
Number of Subjects 24
Sex Both Genders
Age Range 30-44
Body Types Average
Notes for this study:
21 days supplementation of colostrum in persons with HIV/AIDS associated diarrhea (no placebo control) noted significant reductions in stool weight and frequency associated with powdered colostrum () but not encapsulated colostrum (), with the reduction seen with powdered colostrum being from 6.6 defecations daily down to 5.4.

Patients not infected by Cryptosporidium parvum did not experience benefit from powdered colostrum.